« Previous
Next »
Medicine
Volume 36, Issue 12
, Pages 653-657
, December 2008
Autoimmune neurological diseases
References
- . Unravelling the pathogenesis of myasthenia gravis. Nat Rev Immunol. 2002;2(10):797–804
- . Seronegative generalised myasthenia gravis: clinical features, antibodies, and their targets. Lancet Neurol. 2003;2:99–106
- . Steroids and immunosuppressant drugs in myasthenia gravis. Nat Clin Pract Neurol. 2008;4(6):317–327
- . A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group. Neurology. 1998;50(6):1778–1783
- Sustained response to rituximab in anti-AChR and anti-MuSK positive myasthenia gravis patients. J Neuroimmunol. 2008;201:90–94
- . Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2000;55:7–15
- Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med. 1995;332:1467–1474
- . Autoimmune channelopathies. Nat Clin Pract Neurol. 2005;1(1):22–33
- . IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005;202(4):473–477
- Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. 2001;50(1):73–78
- Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127(Pt 3):701–712
PII: S1357-3039(08)00264-8
doi: 10.1016/j.mpmed.2008.09.005
© 2008 Elsevier Ltd. All rights reserved.
« Previous
Next »
Medicine
Volume 36, Issue 12
, Pages 653-657
, December 2008

